Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tuberous Sclerosis × exemestane × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1

Conditions

Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Tuberous Sclerosis 1 Neuroendocrine Tumors 1 Hyperglycemia 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

exemestane 1 Injections 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07369505 2026-01-27

Sapu003 in Advanced mTOR-sensitive Solid Tumors

SAPU NANO (US) LLC

Phase 1 Recruiting

EndocrineGastrointestinalGenitourinaryNET

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡